Randomised clinical trial to determine the incidence of Cystoid Macular Oedema (CMO) after cataract surgery with Intraocular Cefuroxime.

ISRCTN ISRCTN13489716
DOI https://doi.org/10.1186/ISRCTN13489716
Secondary identifying numbers N0084132811
Submission date
30/09/2004
Registration date
30/09/2004
Last edited
06/01/2010
Recruitment status
No longer recruiting
Overall study status
Completed
Condition category
Surgery
Prospectively registered
Protocol
Statistical analysis plan
Results
Individual participant data

Plain English Summary

Not provided at time of registration

Contact information

Dr Hamish McKee
Scientific

Hull & East Yorkshire Eye Hospital
Anlaby Road
Hull
HU3 2JZ
United Kingdom

Email Hamish.Mckee@hey.nhs.uk

Study information

Study designRandomised controlled trial
Primary study designInterventional
Secondary study designRandomised controlled trial
Study setting(s)Hospital
Study typeTreatment
Scientific title
Study hypothesisTo evaluate the risk of toxicity by determining the incidence of Cystoid Macular Oedema (CMO) when intraocular Cefuroxime is used at the end of cataract surgery and comparing this incidence when it is not used.
Ethics approval(s)Not provided at time of registration
ConditionSurgery: Cataract
Intervention120 patients, aged above 50 years having cataract surgery, 60 of which will receive intraocular cefuroxime, and 60 of which will not receive intraocular cefuroxime.
Intervention typeDrug
Pharmaceutical study type(s)
PhaseNot Specified
Drug / device / biological / vaccine name(s)Cefuroxime
Primary outcome measureNot provided at time of registration
Secondary outcome measuresNot provided at time of registration
Overall study start date19/09/2003
Overall study end date31/07/2004

Eligibility

Participant type(s)Patient
Age groupSenior
SexNot Specified
Target number of participants120
Participant inclusion criteria120 patients, aged above 50 years having cataract surgery.
Participant exclusion criteriaNot provided at time of registration
Recruitment start date19/09/2003
Recruitment end date31/07/2004

Locations

Countries of recruitment

  • England
  • United Kingdom

Study participating centre

Hull & East Yorkshire Eye Hospital
Hull
HU3 2JZ
United Kingdom

Sponsor information

Department of Health
Government

Richmond House
79 Whitehall
London
SW1A 2NL
United Kingdom

Website http://www.dh.gov.uk/Home/fs/en

Funders

Funder type

Government

The North and South Bank Research and Development Consortium (UK)

No information available

Results and Publications

Intention to publish date
Individual participant data (IPD) Intention to shareNo
IPD sharing plan summaryNot provided at time of registration
Publication and dissemination planNot provided at time of registration
IPD sharing plan

Study outputs

Output type Details Date created Date added Peer reviewed? Patient-facing?
Results article results 01/06/2005 Yes No